Shiga Toxin Producing Escherichia coli

Clinics in Laboratory Medicine

Volumn 35, Issue 2, 2015, Pages 247-272

  Bryan, Allen ^a   Youngster, Ilan ^b   McAdam, Alexander J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Enterohemorrhagic Escherichia coli; Escherichia coli O157; Gastroenteritis; Shiga toxin producing Escherichia coli

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; ESCHERICHIA COLI O157 ANTIGEN; SHIGA TOXIN; SORBITOL; SORBITOL MACCONKEY AGAR; UNCLASSIFIED DRUG;

ASYMPTOMATIC INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE STUDY; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; EUROPE; FOOD CONTAMINATION; FOOD INTAKE; GENE AMPLIFICATION; GENE TARGETING; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; IMMUNOASSAY; INCIDENCE; LABORATORY TEST; MOLECULAR DIAGNOSIS; NOMENCLATURE; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TOXIN SYNTHESIS; UNITED STATES; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CHEMISTRY; CLASSIFICATION; COMPLICATION; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; PROCEDURES;

BACTERIAL TYPING TECHNIQUES; ESCHERICHIA COLI INFECTIONS; GENOME, BACTERIAL; HUMANS; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI; UNITED STATES;

EID: 84929960418     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2015.02.004     Document Type: Review

References (158)

1. Iyoda S., Tamura K., Itoh K., et al. Inducible stx2 phages are lysogenized in the enteroaggregative and other phenotypic Escherichia coli O86:HNM isolated from patients. FEMS Microbiol Lett 2000, 191(1):7-10.
2. Morabito S., Karch H., Mariani-Kurkdjian P., et al. Enteroaggregative, Shiga toxin-producing Escherichia coli O111:H2 associated with an outbreak of hemolytic-uremic syndrome. JClin Microbiol 1998, 36(3):840-842.
3. Frank C., Werber D., Cramer J.P., et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. NEngl J Med 2011, 365(19):1771-1780.
4. Barrett T.J., Kaper J.B., Jerse A.E., et al. Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. JInfect Dis 1992, 165(5):979-980.
5. Karmali M.A. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989, 2(1):15-38.
6. Konowalchuk J., Speirs J.I., Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977, 18(3):775-779.
7. Lan R., Alles M.C., Donohoe K., et al. Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun 2004, 72(9):5080-5088.
8. Huang A., Friesen J., Brunton J.L. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. JBacteriol 1987, 169(9):4308-4312.
9. Datz M., Janetzki-Mittmann C., Franke S., et al. Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl Environ Microbiol 1996, 62(3):791-797.
10. Strockbine N.A., Jackson M.P., Sung L.M., et al. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. JBacteriol 1988, 170(3):1116-1122.
11. Seidah N.G., Donohue-Rolfe A., Lazure C., et al. Complete amino acid sequence of Shigella toxin B-chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. JBiol Chem 1986, 261(30):13928-13931.
12. Scotland S.M., Smith H.R., Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet 1985, 2(8460):885-886.
13. Strockbine N.A., Marques L.R., Newland J.W., et al. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 1986, 53(1):135-140.
14. O'Brien A.D., Newland J.W., Miller S.F., et al. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 1984, 226(4675):694-696.
15. Smith H.W., Green P., Parsell Z. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. JGen Microbiol 1983, 129(10):3121-3137.
16. Fraser M.E., Chernaia M.M., Kozlov Y.V., et al. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat Struct Biol 1994, 1(1):59-64.
17. Fraser M.E., Fujinaga M., Cherney M.M., et al. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. JBiol Chem 2004, 279(26):27511-27517.
18. Beddoe T., Paton A.W., Le Nours J., et al. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 2010, 35(7):411-418.
19. Calderwood S.B., Mekalanos J.J. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. JBacteriol 1987, 169(10):4759-4764.
20. Los J.M., Los M., Wegrzyn G., et al. Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog 2009, 47(6):289-298.
21. McGannon C.M., Fuller C.A., Weiss A.A. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother 2010, 54(9):3790-3798.
22. Kolling G.L., Matthews K.R. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 1999, 65(5):1843-1848.
23. Yokoyama K., Horii T., Yamashino T., et al. Production of Shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. FEMS Microbiol Lett 2000, 192(1):139-144.
24. Shimizu T., Ohta Y., Noda M. Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect Immun 2009, 77(7):2813-2823.
25. Jacewicz M.S., Mobassaleh M., Gross S.K., et al. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. JInfect Dis 1994, 169(3):538-546.
26. Holgersson J., Jovall P.A., Breimer M.E. Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. JBiochem 1991, 110(1):120-131.
27. Schuller S., Heuschkel R., Torrente F., et al. Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect 2007, 9(1):35-39.
28. Brigotti M., Tazzari P.L., Ravanelli E., et al. Clinical relevance of Shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Pediatr Infect Dis J 2011, 30(6):486-490.
29. Brigotti M., Carnicelli D., Arfilli V., et al. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. JImmunol 2013, 191(9):4748-4758.
30. Schuller S. Shiga toxin interaction with human intestinal epithelium. Toxins (Basel) 2011, 3(6):626-639.
31. Boyd B., Lingwood C. Verotoxin receptor glycolipid in human renal tissue. Nephron 1989, 51(2):207-210.
32. Sandvig K., van Deurs B. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol Rev 1996, 76(4):949-966.
33. Garred O., van Deurs B., Sandvig K. Furin-induced cleavage and activation of Shiga toxin. JBiol Chem 1995, 270(18):10817-10821.
34. Endo Y., Tsurugi K., Yutsudo T., et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988, 171(1-2):45-50.
35. Smith W.E., Kane A.V., Campbell S.T., et al. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells. Infect Immun 2003, 71(3):1497-1504.
36. Beebakhee G., Louie M., De Azavedo J., et al. Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7. FEMS Microbiol Lett 1992, 70(1):63-68.
37. McDaniel T.K., Jarvis K.G., Donnenberg M.S., et al. Agenetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci USA 1995, 92(5):1664-1668.
38. Donnenberg M.S., Kaper J.B., Finlay B.B. Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol 1997, 5(3):109-114.
39. Louie M., de Azavedo J., Clarke R., et al. Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect 1994, 112(3):449-461.
40. Doughty S., Sloan J., Bennett-Wood V., et al. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect Immun 2002, 70(12):6761-6769.
41. Paton A.W., Srimanote P., Woodrow M.C., et al. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun 2001, 69(11):6999-7009.
42. Centers for Disease Control and Prevention (CDC) Outbreak of Escherichia coli O104:H4 infections associated with sprout consumption - Europe and North America, May-July 2011. MMWR Morb Mortal Wkly Rep 2013, 62(50):1029-1031.
43. Bielaszewska M., Mellmann A., Zhang W., et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011, 11(9):671-676.
44. Brzuszkiewicz E., Thurmer A., Schuldes J., et al. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol 2011, 193(12):883-891.
45. Ho C.C., Yuen K.Y., Lau S.K., et al. Rapid identification and validation of specific molecular targets for detection of Escherichia coli O104:H4 outbreak strain by use of high-throughput sequencing data from nine genomes. JClin Microbiol 2011, 49(10):3714-3716.
46. Rohde H., Qin J., Cui Y., et al. Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. NEngl J Med 2011, 365(8):718-724.
47. Rasko D.A., Webster D.R., Sahl J.W., et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. NEngl J Med 2011, 365(8):709-717.
48. Kauffmann F. The serology of the coli group. JImmunol 1947, 57(1):71-100.
49. Wolf M.K. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev 1997, 10(4):569-584.
50. Rangel J.M., Sparling P.H., Crowe C., et al. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 2005, 11(4):603-609.
51. Byrne L., Vanstone G.L., Perry N.T., et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. JMed Microbiol 2014, 63(Pt 9):1181-1188.
52. Karmali M.A., Steele B.T., Petric M., et al. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983, 1(8325):619-620.
53. Riley L.W., Remis R.S., Helgerson S.D., et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. NEngl J Med 1983, 308(12):681-685.
54. O'Brien A.O., Lively T.A., Chen M.E., et al. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1983, 1(8326 Pt 1):702.
55. Wells J.G., Davis B.R., Wachsmuth I.K., et al. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. JClin Microbiol 1983, 18(3):512-520.
56. Centers for Disease Control and Prevention (CDC) Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis-New York and North Carolina, 2005. MMWR Morb Mortal Wkly Rep 2006, 55(38):1042-1045.
57. Centers for Disease Control and Prevention (CDC) Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli-Connecticut, 2000-2005. MMWR Morb Mortal Wkly Rep 2007, 56(2):29-31.
58. Centers for Disease Control and Prevention (CDC) Vital signs: incidence and trends of infection with pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep 2011, 60(22):749-755.
59. Smith J.L., Fratamico P.M. Gunther NWt. Shiga toxin-producing Escherichia coli. Adv Appl Microbiol 2014, 86:145-197.
60. Davis T.K., McKee R., Schnadower D., et al. Treatment of Shiga toxin-producing Escherichia coli infections. Infect Dis Clin North Am 2013, 27(3):577-597.
61. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365(9464):1073-1086.
62. Su C., Brandt L.J. Escherichia coli O157:H7 infection in humans. Ann Intern Med 1995, 123(9):698-714.
63. Boyce T.G., Swerdlow D.L., Griffin P.M. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. NEngl J Med 1995, 333(6):364-368.
64. Mayer C.L., Leibowitz C.S., Kurosawa S., et al. Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) 2012, 4(11):1261-1287.
65. Marshall J.K. Post-infectious irritable bowel syndrome following water contamination. Kidney Int Suppl 2009, (112):S42-S43.
66. Ho N.K., Henry A.C., Johnson-Henry K., et al. Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection. Can J Gastroenterol 2013, 27(5):281-285.
67. Bielaszewska M., Mellmann A., Bletz S., et al. Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis 2013, 56(10):1373-1381.
68. Rahal E.A., Kazzi N., Nassar F.J., et al. Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Front Cell Infect Microbiol 2012, 2:138.
69. Hauswaldt S., Nitschke M., Sayk F., et al. Lessons learned from outbreaks of Shiga toxin producing Escherichia coli. Curr Infect Dis Rep 2013, 15(1):4-9.
70. Thielman N.M., Guerrant R.L. Clinical practice. Acute infectious diarrhea. NEngl J Med 2004, 350(1):38-47.
71. Nelson J.M., Griffin P.M., Jones T.F., et al. Antimicrobial and antimotility agent use in persons with Shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites. Clin Infect Dis 2011, 52(9):1130-1132.
72. Bell B.P., Griffin P.M., Lozano P., et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997, 100(1):E12.
73. Proulx F., Turgeon J.P., Delage G., et al. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. JPediatr 1992, 121(2):299-303.
74. Smith K.E., Wilker P.R., Reiter P.L., et al. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J 2012, 31(1):37-41.
75. Wong C.S., Mooney J.C., Brandt J.R., et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012, 55(1):33-41.
76. Wong C.S., Jelacic S., Habeeb R.L., et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. NEngl J Med 2000, 342(26):1930-1936.
77. Kimmitt P.T., Harwood C.R., Barer M.R. Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 2000, 6(5):458-465.
78. Bielaszewska M., Idelevich E.A., Zhang W., et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother 2012, 56(6):3277-3282.
79. Nitschke M., Sayk F., Hartel C., et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 2012, 307(10):1046-1052.
80. Vonberg R.P., Hohle M., Aepfelbacher M., et al. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis 2013, 56(8):1132-1140.
81. Lapeyraque A.L., Malina M., Fremeaux-Bacchi V., et al. Eculizumab in severe Shiga-toxin-associated HUS. NEngl J Med 2011, 364(26):2561-2563.
82. Menne J., Nitschke M., Stingele R., et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012, 345:e4565.
83. Mukhopadhyay S., Linstedt A.D. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 2012, 335(6066):332-335.
84. Majowicz S.E., Scallan E., Jones-Bitton A., et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis 2014, 11(6):447-455.
85. Pruimboom-Brees I.M., Morgan T.W., Ackermann M.R., et al. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci USA 2000, 97(19):10325-10329.
86. Conedera G., Mattiazzi E., Russo F., et al. Afamily outbreak of Escherichia coli O157 haemorrhagic colitis caused by pork meat salami. Epidemiol Infect 2007, 135(2):311-314.
87. Ferguson D.D., Scheftel J., Cronquist A., et al. Temporally distinct Escherichia coli 0157 outbreaks associated with alfalfa sprouts linked to a common seed source-Colorado and Minnesota, 2003. Epidemiol Infect 2005, 133(3):439-447.
88. Grant J., Wendelboe A.M., Wendel A., et al. Spinach-associated Escherichia coli O157:H7 outbreak, Utah and New Mexico, 2006. Emerg Infect Dis 2008, 14(10):1633-1636.
89. Neil K.P., Biggerstaff G., MacDonald J.K., et al. Anovel vehicle for transmission of Escherichia coli O157:H7 to humans: multistate outbreak of E. coli O157:H7 infections associated with consumption of ready-to-bake commercial prepackaged cookie dough-United States, 2009. Clin Infect Dis 2012, 54(4):511-518.
90. Crump J.A., Sulka A.C., Langer A.J., et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. NEngl J Med 2002, 347(8):555-560.
91. Crump J.A., Braden C.R., Dey M.E., et al. Outbreaks of Escherichia coli O157 infections at multiple county agricultural fairs: a hazard of mixing cattle, concession stands and children. Epidemiol Infect 2003, 131(3):1055-1062.
92. Hale C.R., Scallan E., Cronquist A.B., et al. Estimates of enteric illness attributable to contact with animals and their environments in the United States. Clin Infect Dis 2012, 54(Suppl 5):S472-S479.
93. Paunio M., Pebody R., Keskimaki M., et al. Swimming-associated outbreak of Escherichia coli O157:H7. Epidemiol Infect 1999, 122(1):1-5.
94. Friedman M.S., Roels T., Koehler J.E., et al. Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool. Clin Infect Dis 1999, 29(2):298-303.
95. Panaro L., Cooke D., Borczyk A. Outbreak of Escherichia coli O157:H7 in a nursing home-Ontario. Can Dis Wkly Rep 1990, 16(19):90-92.
96. Scallan E., Hoekstra R.M., Angulo F.J., et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17(1):7-15.
97. Scallan E., Mahon B.E., Hoekstra R.M., et al. Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States. Pediatr Infect Dis J 2013, 32(3):217-221.
98. Buchholz U., Bernard H., Werber D., et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. NEngl J Med 2011, 365(19):1763-1770.
99. Beutin L., Martin A. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains. JFood Prot 2012, 75(2):408-418.
100. Gould L.H., Bopp C., Strockbine N., et al. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 2009, 58(RR-12):1-14.
101. Hermos C.R., Janineh M., Han L.L., et al. Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. JClin Microbiol 2011, 49(3):955-959.
102. Schindler E.I., Sellenriek P., Storch G.A., et al. Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. JClin Microbiol 2014, 52(10):3647-3653.
103. Marcon M.J. Point: should all stools be screened for Shiga toxin-producing Escherichia coli?. JClin Microbiol 2011, 49(7):2390-2394.
104. Kiska D.L., Riddell S.W. Counterpoint: should all stools be screened for Shiga toxin-producing Escherichia coli?. JClin Microbiol 2011, 49(7):2394-2397.
105. Bettelheim K.A. Reliability of CHROMagar O157 for the detection of enterohaemorrhagic Escherichia coli (EHEC) O157 but not EHEC belonging to other serogroups. JAppl Microbiol 1998, 85(3):425-428.
106. Church D.L., Emshey D., Semeniuk H., et al. Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory. JClin Microbiol 2007, 45(9):3098-3100.
107. Hirvonen J.J., Siitonen A., Kaukoranta S.S. Usability and performance of CHROMagar STEC medium in detection of Shiga toxin-producing Escherichia coli strains. JClin Microbiol 2012, 50(11):3586-3590.
108. Gouali M., Ruckly C., Carle I., et al. Evaluation of CHROMagar STEC and STEC O104 chromogenic agar media for detection of Shiga toxin-producing Escherichia coli in stool specimens. JClin Microbiol 2013, 51(3):894-900.
109. Gill A., Huszczynski G., Gauthier M., et al. Evaluation of eight agar media for the isolation of shiga toxin-Producing Escherichia coli. JMicrobiol Methods 2014, 96:6-11.
110. Manning S.D., Madera R.T., Schneider W., et al. Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 2007, 13(2):318-321.
111. Zadik P.M., Chapman P.A., Siddons C.A. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. JMed Microbiol 1993, 39(2):155-158.
112. Chapman P.A., Siddons C.A. Acomparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. JMed Microbiol 1996, 44(4):267-271.
113. Karch H., Janetzki-Mittmann C., Aleksic S., et al. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. JClin Microbiol 1996, 34(3):516-519.
114. Farmer J.J., Davis B.R. H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. JClin Microbiol 1985, 22(4):620-625.
115. March S.B., Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. JClin Microbiol 1986, 23(5):869-872.
116. Feng P., Lum R., Chang G.W. Identification of uidA gene sequences in beta-D-glucuronidase-negative Escherichia coli. Appl Environ Microbiol 1991, 57(1):320-323.
117. Feng P., Lampel K.A. Genetic analysis of uidA expression in enterohaemorrhagic Escherichia coli serotype O157:H7. Microbiology 1994, 140(Pt 8):2101-2107.
118. Onoue Y., Konuma H., Nakagawa H., et al. Collaborative evaluation of detection methods for Escherichia coli O157:H7 from radish sprouts and ground beef. Int J Food Microbiol 1999, 46(1):27-36.
119. De Boer E., Heuvelink A.E. Methods for the detection and isolation of Shiga toxin-producing Escherichia coli. Symp Ser Soc Appl Microbiol 2000, 29:133S-143S.
120. Taylor D.E. Bacterial tellurite resistance. Trends Microbiol 1999, 7(3):111-115.
121. Bielaszewska M., Tarr P.I., Karch H., et al. Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates. JClin Microbiol 2005, 43(1):452-454.
122. Orth D., Grif K., Dierich M.P., et al. Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol 2007, 158(2):105-111.
123. Gill A., Martinez-Perez A., McIlwham S., et al. Development of a method for the detection of verotoxin-producing Escherichia coli in food. JFood Prot 2012, 75(5):827-837.
124. Teramura H., Sekiguchi J., Inoue K. Anovel chromogenic screening medium for isolation of enterohemorrhagic Escherichia coli. Biocontrol Sci 2013, 18(2):111-115.
125. Grif K., Orth D., Dierich M.P., et al. Comparison of an immunochromatographic rapid test with enzyme-linked immunosorbent assay and polymerase chain reaction for the detection of Shiga toxins from human stool samples. Diagn Microbiol Infect Dis 2007, 59(1):97-99.
126. Park C.H., Kim H.J., Hixon D.L., et al. Evaluation of the duopath verotoxin test for detection of shiga toxins in cultures of human stools. JClin Microbiol 2003, 41(6):2650-2653.
127. Stapp J.R., Jelacic S., Yea Y.L., et al. Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures. JClin Microbiol 2000, 38(9):3404-3406.
128. Kehl K.S., Havens P., Behnke C.E., et al. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. JClin Microbiol 1997, 35(8):2051-2054.
129. Vallieres E., Saint-Jean M., Rallu F. Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center. JClin Microbiol 2013, 51(2):481-486.
130. Gavin P.J., Peterson L.R., Pasquariello A.C., et al. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga toxin-producing E. coli in stool samples. JClin Microbiol 2004, 42(4):1652-1656.
131. Mackenzie A., Orrbine E., Hyde L., et al. Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools. JClin Microbiol 2000, 38(5):1866-1868.
132. Gerritzen A., Wittke J.W., Wolff D. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay. Clin Lab 2011, 57(11-12):993-998.
133. Chui L., Lee M.C., Malejczyk K., et al. Prevalence of shiga toxin-producing Escherichia coli as detected by enzyme-linked immunoassays and real-time PCR during the summer months in northern Alberta, Canada. JClin Microbiol 2011, 49(12):4307-4310.
134. Botkin D.J., Galli L., Sankarapani V., et al. Development of a multiplex PCR assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Cell Infect Microbiol 2012, 2:8.
135. Barletta F., Ochoa T.J., Cleary T.G. Multiplex real-time PCR (MRT-PCR) for diarrheagenic. Methods Mol Biol 2013, 943:307-314.
136. Delannoy S., Beutin L., Burgos Y., et al. Specific detection of enteroaggregative hemorrhagic Escherichia coli O104:H4 strains by use of the CRISPR locus as a target for a diagnostic real-time PCR. JClin Microbiol 2012, 50(11):3485-3492.
137. Zhang W., Bielaszewska M., Bauwens A., et al. Real-time multiplex PCR for detecting Shiga toxin 2-producing Escherichia coli O104:H4 in human stools. JClin Microbiol 2012, 50(5):1752-1754.
138. Conrad C.C., Gilroyed B.H., McAllister T.A., et al. Synthesis of O-serogroup specific positive controls and real-time PCR standards for nine clinically relevant non-O157 STECs. JMicrobiol Methods 2012, 91(1):52-56.
139. Kagkli D.M., Weber T.P., Van den Bulcke M., et al. Application of the modular approach to an in-house validation study of real-time PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli. Appl Environ Microbiol 2011, 77(19):6954-6963.
140. Paton A.W., Paton J.C. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. JClin Microbiol 1998, 36(2):598-602.
141. Anklam K.S., Kanankege K.S., Gonzales T.K., et al. Rapid and reliable detection of Shiga toxin-producing Escherichia coli by real-time multiplex PCR. JFood Prot 2012, 75(4):643-650.
142. Lefterova M.I., Slater K.A., Budvytiene I., et al. Asensitive multiplex, real-time PCR assay for prospective detection of Shiga toxin-producing Escherichia coli from stool samples reveals similar incidences but variable severities of non-O157 and O157 infections in northern California. JClin Microbiol 2013, 51(9):3000-3005.
143. Chui L., Couturier M.R., Chiu T., et al. Comparison of Shiga toxin-producing Escherichia coli detection methods using clinical stool samples. JMol Diagn 2010, 12(4):469-475.
144. Chui L., Lee M.C., Allen R., et al. Comparison between ImmunoCard STAT!((R)) and real-time PCR as screening tools for both O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. Diagn Microbiol Infect Dis 2013, 77(1):8-13.
145. Wang F., Jiang L., Ge B. Loop-mediated isothermal amplification assays for detecting shiga toxin-producing Escherichia coli in ground beef and human stools. JClin Microbiol 2012, 50(1):91-97.
146. Holland J.L., Louie L., Simor A.E., et al. PCR detection of Escherichia coli O157:H7 directly from stools: evaluation of commercial extraction methods for purifying fecal DNA. JClin Microbiol 2000, 38(11):4108-4113.
147. Persson S., Olsen K.E., Scheutz F., et al. Amethod for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory. Clin Microbiol Infect 2007, 13(5):516-524.
148. Buvens G., De Gheldre Y., Dediste A., et al. Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010. JClin Microbiol 2012, 50(4):1336-1345.
149. Margot H., Cernela N., Iversen C., et al. Evaluation of seven different commercially available real-time PCR assays for detection of shiga toxin 1 and 2 gene subtypes. JFood Prot 2013, 76(5):871-873.
150. Grys T.E., Sloan L.M., Rosenblatt J.E., et al. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. JClin Microbiol 2009, 47(7):2008-2012.
151. Buchan B.W., Olson W.J., Pezewski M., et al. Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin-producing Escherichia coli isolates in stool specimens. JClin Microbiol 2013, 51(12):4001-4007.
152. Koziel M., Kiely R., Blake L., et al. Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay. JClin Microbiol 2013, 51(8):2679-2685.
153. Koziel M., Corcoran D., O'Callaghan I., et al. Validation of the EntericBio Panel II(R) multiplex polymerase chain reaction system for detection of Campylobacter spp., Salmonella spp., Shigella spp., and verotoxigenic E. coli for use in a clinical diagnostic setting. Diagn Microbiol Infect Dis 2013, 75(1):46-49.
154. Cremonesi P., Pisani L.F., Lecchi C., et al. Development of 23 individual TaqMan(R) real-time PCR assays for identifying common foodborne pathogens using a single set of amplification conditions. Food Microbiol 2014, 43:35-40.
155. Anderson N.W., Buchan B.W., Ledeboer N.A. Comparison of the BD MAX enteric bacterial panel to routine culture methods for detection of Campylobacter, enterohemorrhagic Escherichia coli (O157), Salmonella, and Shigella isolates in preserved stool specimens. JClin Microbiol 2014, 52(4):1222-1224.
156. Brooks J.T., Sowers E.G., Wells J.G., et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. JInfect Dis 2005, 192(8):1422-1429.
157. Werber D., Beutin L., Pichner R., et al. Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany. Emerg Infect Dis 2008, 14(11):1803-1806.
158. Hiroi M., Takahashi N., Harada T., et al. Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007). Jpn J Infect Dis 2012, 65(3):198-202.